590 related articles for article (PubMed ID: 18311573)
1. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F
Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
[TBL] [Abstract][Full Text] [Related]
2. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.
Fratzl-Zelman N; Schmidt I; Roschger P; Glorieux FH; Klaushofer K; Fratzl P; Rauch F; Wagermaier W
Bone; 2014 Mar; 60():122-8. PubMed ID: 24296239
[TBL] [Abstract][Full Text] [Related]
3. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.
Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K
Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299
[TBL] [Abstract][Full Text] [Related]
4. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
Rauch F; Lalic L; Roughley P; Glorieux FH
J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
[TBL] [Abstract][Full Text] [Related]
5. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
Garnero P; Schott AM; Prockop D; Chevrel G
Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
[TBL] [Abstract][Full Text] [Related]
6. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
[TBL] [Abstract][Full Text] [Related]
7. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pamidronate in osteogenesis imperfecta type VII.
Cheung MS; Glorieux FH; Rauch F
Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
[TBL] [Abstract][Full Text] [Related]
9. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype.
Sarathchandra P; Pope FM; Kayser MV; Ali SY
J Pathol; 2000 Nov; 192(3):385-95. PubMed ID: 11054723
[TBL] [Abstract][Full Text] [Related]
10. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
Rousseau JC; Chevrel G; Schott AM; Garnero P
Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
[TBL] [Abstract][Full Text] [Related]
11. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.
Cheung MS; Arponen H; Roughley P; Azouz ME; Glorieux FH; Waltimo-Sirén J; Rauch F
J Bone Miner Res; 2011 Feb; 26(2):405-13. PubMed ID: 20721936
[TBL] [Abstract][Full Text] [Related]
12. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
[TBL] [Abstract][Full Text] [Related]
13. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
14. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.
Rauch F; Travers R; Plotkin H; Glorieux FH
J Clin Invest; 2002 Nov; 110(9):1293-9. PubMed ID: 12417568
[TBL] [Abstract][Full Text] [Related]
15. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
[TBL] [Abstract][Full Text] [Related]
17. Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study.
Edouard T; Glorieux FH; Rauch F
J Bone Miner Res; 2011 Sep; 26(9):2245-51. PubMed ID: 21544864
[TBL] [Abstract][Full Text] [Related]
18. Unexpected ultrastructral changes in bone osteiod collagens in osteogenesis imperfecta.
Sarathchandra P; Pope FM
Micron; 2005; 36(7-8):696-702. PubMed ID: 16182545
[TBL] [Abstract][Full Text] [Related]
19. Osteogenesis imperfecta: biochemical studies of bone collagen.
Fujii K; Tanzer ML
Clin Orthop Relat Res; 1977 May; (124):271-7. PubMed ID: 598086
[TBL] [Abstract][Full Text] [Related]
20. Osteogenesis imperfecta at the beginning of bone and joint decade.
Primorac D; Rowe DW; Mottes M; Barisić I; Anticević D; Mirandola S; Gomez Lira M; Kalajzić I; Kusec V; Glorieux FH
Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
